Caribou Biosciences

NASDAQ: CRBU
Pioneering CRISPR genome editing for new medical therapies.

F-Prime Team

Sector

Life Sciences

Category

Therapeutics

Location

Berkeley, CA

Initial Investment

2015
Pioneering CRISPR genome editing for new medical therapies.

Caribou (NASDAQ: CRBU) is a leading company in CRISPR genome editing founded by pioneers of CRISPR-Cas9 biology. Caribou’s proprietary technologies put the company at the forefront of the development of new medical therapies.